Hyperglycaemia may potentiate atherogenesis by inhibiting arterial endothelial nitric oxide (NO) production, enhancing platelet-derived growth factor- (PGDF-) induced vascular smooth muscle cell proliferation, stimulating PAI-1 production, and accumulating advanced glycation end products [6, 35]. Here, SERPINE1 is linked to Hyperglycemia.